New #JITC commentary: "Targeting B7-H3 in patients with metastatic triple-negative breast cancer and brain metastases: an opportunity to “revive” immunotherapy as a treatment strategy?" jitc.bmj.com/content/14/6/e0… @JerzakKasia @UofT_DoM

Congratulations to Dr. Michelle Hladunewich on receiving the Ludwik & Estelle Jus Memorial Human Rights Prize for an Influential Leader and our Business & Administration Director, Kerri Bailey, on receiving the Chancellor’s Leadership Award for a Distinguished Leader from @UofT!

Congratulations to Dr. Carmela Tartaglia and Dr. Gabor Kovacs @KBI_UHN, on their recent feature on @CBC, sharing insights and current research on Chronic Traumatic Encephalopathy (CTE). Read more >> bit.ly/3Qy83HC

Enjoyed presenting our work at @eular_org congress 2026! 🔹Weight independent effects of GLP-1RAs in Psoriatic #Arthritis 🔹 Predictors of enthesophytes and site specific differences Stay tuned for the manuscripts!! #rheumatology #psoriasis

Middle powers must collaborate on health data and health AI. New partnerships could improve datasets, protect sovereignty, and provide better patient care bmj.com/content/393/bmj-2026…

It's our 3rd annual symposium on Physiology & Black Health on June 19th, 10AM-4PM! Speakers include keynote @DrMarjorieDixon, @FinallyFaemus, @dzevela, Dr. Matilda Laar, @SalihLyuba, and maybe YOU! Register or sign up for a trainee flash talk by June 12th: shorturl.at/QUElt

Drs. Yu Qing (Jenny) Huang, Sharon Straus & Jennifer Watt (@UofT_DoM)'s study on dementia rate and care needs in older adults with traumatic brain injury & intersections with social determinants of health: psifoundation.org/funded-res…. #BrainInjuryAwarenessMonth

CONGRESS | #EULAR2026 | POSTER Zahi Touma shares data from a subgroup analysis of the LASER study comparing anifrolumab (n = 354) vs RW SoC (n = 561) by baseline organ damage status in patients with active #SLE (N = 915). • SDI = 0 at baseline: patients receiving anifrolumab accrued, on average, 0.430 fewer SDI points vs RW SoC over 4 years; p < 0.001. • SDI ≥1 at baseline: patients receiving anifrolumab accrued, on average, 0.499 fewer SDI points vs RW SoC; p < 0.001. • Compared with RW SoC, anifrolumab was associated with a 60.8% lower risk of new organ damage accrual over 4 years in patients with baseline SDI = 0 (HR, 0.392; p = 0.014) and a 46.0% lower risk in those with baseline SDI ≥1 (HR, 0.540; p = 0.109). Anifrolumab was associated with lower organ damage accrual regardless of baseline damage status. Follow our live feed for more updates: bit.ly/4wS95Pf Intended for HCPs only. This congress coverage is independently supported by pharmaceutical companies, who are allowed no influence on the content; a full list of supporters can be found on our website. #RheumTwitter #rheumatology #MedNews #MedEd #MedicalCongress #lupus @ZahiTouma @UHN @UofT @UofT_DoM

New #AdvanceAccess research from JAMMI examines the effectiveness of combining daptomycin and linezolid to treat serious Enterococcus bloodstream infections, where standard antibiotics can fall short. Read the full study: bit.ly/JAMMI_aa4 @UofT_DoM

When multiple sclerosis reshaped her career, Dr. Erin Norris redefined what it means to thrive in medicine. Last month, she received the Canadian Medical Association’s Dr. Ashok Muzumdar Memorial Award for Physicians with Disabilities. → deptmedicine.utoronto.ca/new…

Applications are open for the 2026-2028 Master Teacher Program cohort! This two-year certificate course is designed for full time faculty members, clinical fellows including PGY5s, and clinical associates with major teaching responsibilities. deptmedicine.utoronto.ca/mas…

National health data platform founded by Drs. Amol Verma & Fahad Razak, Unity Health physicians, is a key pillar in Canada's new AI Strategy. The platform – called VITAL – will receive up to $100M in federal funding to expand nationally. theglobeandmail.com/business…

We spoke with Eliot Phillipson Clinician-Scientist Training Program trainee Dr. Inna Gong about what inspired her to join the program, what she’s gained from the experience, and her current research. Here’s what she had to say: deptmedicine.utoronto.ca/new…

Gastroenterology education lead at @SHNcares, Dr. Grant Chen, recently appeared on our department's podcast to discuss U of T's new gastroenterology rotation at @SHNcares for PGY5 residents, which will be launching next academic year. → open.spotify.com/episode/3et…

D. Richard Horner's research on the physiology of sleep and breathing has paved the way for a new sleep apnea treatment that recently reported positive results in a phase 3 clinical trial. temertymedicine.utoronto.ca/…

How worried should we be about hantavirus? #TemertyMed Dr. Fahad Razak addressed common concerns and broke down the science on @therundowntvo. bit.ly/4wNeS8I

What are peptides? #TemertyMed Dr. Samir Gupta explains the science behind peptides, how the term got co-opted on social media and the potential risks of unregulated wellness trends. 🎧️ bit.ly/49HBTzO

Drs. Brian Ballios & Thomas Wright (@UofT_DoM)'s study development and validation of machine learning models to screen for HCQ retinal toxicity: psifoundation.org/funded-res… #VisionHealthMonth

Dr. Edward Margolin (@UofT_DoM)'s study on development of an artificial intelligence-powered clinical decision support system for neuro-ophthalmology in specialized and primary care settings: psifoundation.org/funded-res… #VisionHealthMonth

Congrats to all the award recipients at yet another fantastic GIM research day! (Including our very own @YaseenWid) 🎉